Mitomycin FDA Link Generic

An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.

Also Known As:

Mitomycin-C; Mutamycin; Ametycine; Mitocin-C; NSC-26980; Mitocin C; MitocinC; NSC 26980; NSC26980; Mitomycin C; Azirino(2',3':3,4)pyrrolo(1,2- a)indole- 4,7- dione, 6- amino- 8- (((aminocarbonyl)oxy)methyl)- 1,1a,2,8,8a,8b- hexahydro- 8a- methoxy- 5- methyl- , (1aS-(1aalpha,8beta,8aalpha,8balpha))-

Pharmalogical Action Categories:

Alkylating Agents
Antibiotics, Antineoplastic
Cross-Linking Reagents
Nucleic Acid Synthesis Inhibitors

Organic Chemicals: 133
- Quinones: 434
  - Indolequinones: 12
    - Mitomycins: 11
      - Mitomycin: 7989
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azirines
    - Mitomycins: 11
      - Mitomycin: 7989
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indolequinones: 12
        Mitomycins: 11
        Mitomycin: 7989

Jannis Spyridakis Selected Research

Jannis Spyridakis Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure